Compare Natera Inc. Common Stock (NTRA) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Zoom Video Communications, Inc. — how do they compare? Natera Inc. Common Stock trades at $393.27 (market cap $57.03B), while Zoom Video Communications, Inc. trades at $93.85 (market cap $27.56B). The key difference: Natera Inc. Common Stock is far larger — about 2.1× Zoom Video Communications, Inc.'s market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Zoom Video Communications, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Zoom Video Communications, Inc. for 92 Days on average.
| NTRA | ZM | |
|---|---|---|
Market Cap | $57.03B | $27.56B |
Volume | 1,131,157 | 3,481,453 |
Sector | Health | Technology |
52-Week High | $425.64 | $111.88 |
52-Week Low | $179.42 | $72.72 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $56.18B | $20.38B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Zoom Communications (ZM) trades at $98.16, showing modest daily gains of 0.22%. The stock maintains a bullish technical stance with strong moving average signals, though RSI levels suggest potential overbought conditions near-term. Fundamentally, the company demonstrates robust profitability with 77.3% gross margins and 65.19% net income margin, while recent earnings show mixed performance with two beats and one miss in the last three quarters. The company continues to innovate with AI-powered revenue solutions and strategic board appointments.
Zoom presents a compelling investment case with attractive valuation metrics including a 9.11 P/E ratio and analyst consensus price target of $118.08 offering 20% upside potential. However, investors face risks from competitive pressures in the communications software space and potential volatility from the company's significant stake in Anthropic ahead of its anticipated IPO. The stock's current technical overbought condition warrants caution despite strong institutional support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
